TYPE 2 DIABETES MELLITUS

This adverse event was reported 33331 times

These drugs are most commonly taken by patients reporting TYPE 2 DIABETES MELLITUS:

# Drug Count
0 ATORVASTATIN CALCIUM 11261
1 QUETIAPINE 5971
2 PREDNISONE 4866
3 METHOTREXATE SODIUM 4533
4 ADALIMUMAB 4442
5 METHOTREXATE 4255
6 ALENDRONATE SODIUM 4054
7 RITUXIMAB 4021
8 DICLOFENAC SODIUM 3996
9 FOLIC ACID 3948
See all common drugs associated with TYPE 2 DIABETES MELLITUS

TYPE 2 DIABETES MELLITUS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 TRIPROLIDINE HYDROCHLORIDE 124 0.6889
1 TRICLOSAN 217 0.4064
2 CAFFEINE CITRATE 689 0.3049
3 DICLOFENAC POTASSIUM TABLETS 2094 0.2501
4 CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE 159 0.2484
5 PSEUDOEPHEDRINE HCL 2587 0.2361
6 HYDROCORTISONE BUTYRATE 432 0.2262
7 NEOMYCIN OINTMENT 528 0.2221
8 CORTISONE ACETATE 2682 0.2185
9 DICLOFENAC POTASSIUM 2098 0.1953
See all drugs enriched for association with TYPE 2 DIABETES MELLITUS

TYPE 2 DIABETES MELLITUS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Antirheumatic Agent [EPC] 3849 0.0367
1 Antiseptic [EPC] 132 0.0307
2 Interleukin-6 Receptor Antagonist [EPC] 4065 0.0300
3 Aminosalicylate [EPC] 3805 0.0289
4 Interleukin-12 Antagonist [EPC] 2843 0.0278
5 Histamine-1 Receptor Antagonist [EPC] 2239 0.0271
6 Endoglycosidase [EPC] 252 0.0256
7 Selective T Cell Costimulation Modulator [EPC] 3423 0.0249
8 Substance P/Neurokinin-1 Receptor Antagonist [EPC] 444 0.0228
9 l-Thyroxine [EPC] 1 0.0208
See all drug classes enriched for association with TYPE 2 DIABETES MELLITUS